Author: Brittney Wheeler

A study in mice by researchers at the School of Medicine indicates that brain injury can lead to brain tumors in susceptible individuals.

In a bid to improve sexual health and reduce health disparities in the St. Louis area, Washington University infectious diseases physicians are expanding testing and treatment services for sexually transmitted infections in north St. Louis County.

Charles Goldfarb, MD, has been named the inaugural Richard H. Gelberman, MD, Distinguished Professor in Orthopaedic Surgery at Washington University School of Medicine in St. Louis.

School of Medicine researchers have identified how the body’s own immune response to HIV is responsible for the T cell death that characterizes this viral infection.

Yunfeng Ge is an avid bird and nature lover. Her extensive research and volunteer work has prepared her for life after graduation. She plans to pursue conservation work and eventually attend graduate school to study ecology.

Several distinguished speakers, faculty members and student leaders will take part in Commencement recognition ceremonies for Class of 2024 graduates and their families and guests May 10-13 at Washington University in St. Louis.

Nine researchers at the School of Medicine have received funding from the Longer Life Foundation — a cooperative effort between the School of Medicine and the Reinsurance Group of America. The foundation supports research aimed at improving human health, wellness and longevity.

Robert Schmidt, MD, PhD, a professor of pathology and immunology at Washington University School of Medicine in St. Louis, has curated a collection of over 33,000 individually annotated neuropathology images that are now available as a resource to the Washington University and international neuroscience community via a newly launched website.

Zainab Mahmoud, MD, an instructor in medicine at Washington University School of Medicine in St. Louis, has been awarded the Dr. Nanette K. Wenger Research Goes Red Award from the American Heart Association.

Researchers at Washington University School of Medicine in St. Louis have received a $6.2 million grant from the National Institutes of Health (NIH) to develop a gene therapy that would modify the immune system’s B cells to spur them to produce broadly neutralizing antibodies against HIV.